Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

Folk singer-songwriter Peter Yarrow, most known as a member of the trio Peter, Paul and Mary, has died at 86 years old. The ...

Paul G. Pinsky, the longtime state legislator who now heads the Maryland Energy Administration (MEA), told his staff Monday ...

If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, ...

Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in ...

Matthew R. Zibelman, MD, discusses treatment options in muscle-invasive, perioperative, and metastatic bladder cancer.

Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...

Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder ...

In an interview with HT Lifestyle, Dr. Rajesh Kumar Reddy Adapala, Department of Uro – oncology & Robotics, Asian Institute ...

EXCLUSIVE - Cruel bladder cancer may have found a determined new adversary after an experimental drug have proven to not only ...